Radiopharmaceutical Market To Power Robustly And To Witness Profitable Growth During The Forecast Period 2024-2030

Sachin Solapure Sachin Solapure
Oct 14, 2024 - 17:30
5

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


The Global Radiopharmaceutical Market was valued at USD 10.21 Billion in 2022 and is projected to reach USD 19.50 Billion by 2032, registering a CAGR of 7.40% for the forecast period 2023-2032.
 
The Radiopharmaceutical Market size study shifts its attention to in-depth business challenges, defined investment opportunities, market share coupled with product type and applications, key companies responsible for the production, and upcoming market opportunities.
 
Get Free Exclusive Sample of this Premium Report at: https://isayresearch.com/sample/2163
 
The report aims to offer a comprehensive analysis on the global Radiopharmaceutical market. It concentrates on the market dynamics, technological inclinations, and understandings on different end-user industries and product types. Additionally, it examines the key players and the competitive landscape in the global Radiopharmaceutical market.
 
List of Prominent Players: 
 
  • Bayer AG
  • Curium Pharma
  • Lantheus Holdings, Inc.
  • Cardinal Health Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Iso-Tex Diagnostics, Inc.
  • Siemens AG
  • Jubilant Pharmova Limited
  • General Electric Company
 
 
Segmentation of Global Radiopharmaceutical Market:
 
By Radioisotopes
  • Iodine I
  • Gallium 68
  • Technetium 99m
  • Fluorine 18
  • Others
By Application
  • Cardiology
  • Cancer
  • Others
  • By Type
  • Therapeutic
  • Diagnostic
 
By End-Use
  • Hospitals and Clinics
  • Medical Imaging Centers
  • Others
 
Market segment by Region, regional analysis covers
 
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
 
Report Target Clients:
 
Investors and Private Equity Firms
Radiopharmaceutical Providers
Suppliers as well as Distributors
Government and Regulatory Agencies
End users
 
 
Company Profile:
 
iSay Research is a leading market research company dedicated to providing comprehensive and actionable insights to businesses across various industries. With a focus on delivering accurate data and analysis, we help companies make informed decisions and stay ahead in today's dynamic market landscape.
 
Contact :
 
iSay Solutions LLC
166 Geary St. 
15th Floor Suite #212, 
San Francisco, California 94108, 
United States

Tags: